HC Wainwright assumed coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO) in a research report released on Monday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $124.00 target price on the stock.

Shares of Taro Pharmaceutical Industries (TARO) opened at $101.35 on Monday. The stock has a market capitalization of $4,091.21, a price-to-earnings ratio of 19.68 and a beta of 0.64. Taro Pharmaceutical Industries has a 1-year low of $93.01 and a 1-year high of $128.46.

How to Become a New Pot Stock Millionaire

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wells Fargo & Company MN grew its holdings in shares of Taro Pharmaceutical Industries by 11.2% during the 2nd quarter. Wells Fargo & Company MN now owns 1,685 shares of the company’s stock worth $189,000 after purchasing an additional 170 shares in the last quarter. ARK Investment Management LLC acquired a new stake in shares of Taro Pharmaceutical Industries during the 4th quarter worth $247,000. Scotia Capital Inc. acquired a new stake in shares of Taro Pharmaceutical Industries during the 4th quarter worth $265,000. Parametrica Management Ltd acquired a new stake in shares of Taro Pharmaceutical Industries during the 4th quarter worth $306,000. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Taro Pharmaceutical Industries by 176.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,995 shares of the company’s stock worth $314,000 after purchasing an additional 1,913 shares in the last quarter. 12.26% of the stock is currently owned by institutional investors.

WARNING: “Taro Pharmaceutical Industries (TARO) Research Coverage Started at HC Wainwright” was first reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://www.dailypolitical.com/2018/03/15/taro-pharmaceutical-industries-taro-research-coverage-started-at-hc-wainwright.html.

Taro Pharmaceutical Industries Company Profile

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.